NABRIVA THERAPEUTICS PLC SHS
(G63637105)
ファンドの報告 NABRIVA THERAPEUTICS PLC SHS 13F提出書類による
商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
---|---|---|---|---|---|
Orbimed Advisors LLC | 4,644,600 | $11,286k | Jun 30, 2019 | Aug 14, 2019 | |
Frazier Management LLC | 4,256,526 | $10,343k | Jun 30, 2019 | Aug 14, 2019 | |
VIVO Capital LLC | 4,039,139 | $9,815k | Jun 30, 2019 | Aug 13, 2019 | |
Rock Springs Capital Management LP | 1,600,000 | $3,888k | Jun 30, 2019 | Aug 14, 2019 | |
Granahan Investment Management Inc | 231,754 | $563k | Jun 30, 2019 | Aug 14, 2019 | |
MSD Partners LP | 50,000 | $122k | Jun 30, 2019 | Aug 14, 2019 | |
Sectoral Asset Management Inc | 38,255 | $93k | Jun 30, 2019 | Aug 14, 2019 | |
Gabelli Funds LLC | 17,559 | $43k | Jun 30, 2019 | Aug 2, 2019 |